Year: 2026
Type: preprint
Abstract: Osteoarthritis (OA) is a leading cause of pain and disability worldwide, yet disease-modifying treatments remain unavailable. Synovitis contributes to OA pain and progression, but its metabolic drivers remain poorly understood. Using untargeted plasma metabolomics in 471 participants in the Osteoarthritis Initiative (OAI) cohort, we identified circulating choline as the only metabolite shared by two distinct MRI-defined synovitis phenotypes and found that it was associated with radiographic progression over 48 months. A plasma metabolomic signature of choline-rich foods linked potential dietary sources of choline to circulating levels and synovitis. In human synovial tissue, we identified choline transport and phosphorylation machinery in fibroblasts and demonstrated that increased choline availability promotes their inflammatory and migratory responses. Conversely, pharmacological inhibition of choline kinase α attenuated pathogenic fibroblast behavior and cartilage inflammatory responses and reduced synovitis and structural joint damage in two mouse models. These findings identify choline metabolism as a previously unrecognized, therapeutically targetable pathway in OA, connecting systemic metabolism and potential dietary influences to synovial inflammation and joint pathology.
Source: Research Square
Authors: Monica Guma, Rocio Paz-Gonzalez, Martha Cedeño, Alecio F Lombardi, Harsha Gouda, Helena Mannochio-Russo, Vincent Charron-Lamoureux, Roxana Coras, Rebecca Latham, Jessica Murillo-Saich, Marta Sala-Climent, Nathan Argel, Zhuoran Chen, Julius Agongo, Shanzay Ahmed, Lucia Lourido, Valentina Calamia, Adnan Cutuk, Robert Sah, Ignacio Rego Perez, Cristina Ruiz-Romero, Francisco J. Blanco, Eric Y Chang, Elsa Sanchez-Lopez, Ru Liu-Bryan, Nancy Lane, Pieter Dorrestein
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236862613
